AlphaYouJB
Insider buying
James B. Tananbaum bought $2.5M of Latigo Biotherapeutics, Inc. (LTGO) stock
James B. Tananbaum, Dir, 10% of Latigo Biotherapeutics, Inc. (LTGO), bought 140,000 shares of LTGO stock worth $2.5M, per an SEC Form 4 filed Aug 11, 2026.
It was an open-market purchase.
The trade happened on Aug 10, 2026, 1 day before it was made public.
LTGO has moved +13.7% since the trade date, from $18.56 to $21.11 (Sep 21, 2026 close).
- Traded
- Aug 10, 2026
- Disclosed
- Aug 11, 2026
- Filing delay
- 1 day
- Price since
- +13.7%
- Role
- Dir, 10%
- Source
- SEC Form 4
More LTGO insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.